Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yu-lin Lin

Showing results (31-40 of 64) with videos related to

Pageof 7
Sort By:
Oncology|December 22, 2007
Prognostic factors in extrapulmonary small cell carcinomas. A large retrospective studyYu-Lin Lin, Chih-Yuan Chung, Cheng-Shyong Chang, et al.
Histopathology|October 27, 2015
Traditional serrated adenoma with BRAF mutation is associated with synchronous/metachronous BRAF-mutated serrated lesionsJia-Huei Tsai, Chien-Hsuan Cheng, Chien-Chuan Chen, et al.
World Journal of Surgical Oncology|November 7, 2014
Neoadjuvant bevacizumab and chemoradiotherapy in locally advanced rectal cancer: early outcome and technical impact on toxicityChia-Chun Wang, Jin-Tung Liang, Chiao-Ling Tsai, et al.
Anticancer Research|July 31, 2012
Metastasectomy of Krukenberg tumors may be associated with survival benefits in patients with metastatic gastric cancerLi-Chun Lu, Yu-Yun Shao, Chih-Hung Hsu, et al.
BMC Cancer|September 26, 2023
Etiological analysis of infection after CRS + HIPEC in patients with PMPRui Yang, Xin Zhao, Yu-Bin Fu, et al.
Molecular Oncology|October 30, 2012
MEK inhibitors reverse resistance in epidermal growth factor receptor mutation lung cancer cells with acquired resistance to gefitinibMing-Hung Huang, Jih-Hsiang Lee, Ya-Ju Chang, et al.
Clinical and Translational Gastroenterology|December 15, 2012
CXCR4 expression predicts early liver recurrence and poor survival after resection of pancreatic adenocarcinomaWei-Chih Liao, Hsiu-Po Wang, Hsin-Yi Huang, et al.
Cancer Medicine|December 10, 2019
Establishment of patient-derived xenograft model of peritoneal mucinous carcinomatosis with signet ring cells and in vivo study on the efficacy and toxicity of intraperitoneal injection of 5-fluorouracilYu-Lin Lin, Jue Zhang, Feng-Cai Yan, et al.
Fish & Shellfish Immunology|March 17, 2024
Establishment of a cobia (Rachycentron canadum) gill cell line: A valuable tool for immune response studiesThi Hang Ho, Hoang Trieu Quan Tran, Chun-Hung Liu, et al.
BMC Cancer|May 26, 2016
Primary tumor site is a useful predictor of cetuximab efficacy in the third-line or salvage treatment of KRAS wild-type (exon 2 non-mutant) metastatic colorectal cancer: a nationwide cohort studyKuo-Hsing Chen, Yu-Yun Shao, Ho-Min Chen, et al.
Pageof 7

Showing results (31-40 of 64) with videos related to

Sort By:
Pageof 7
Oncology|December 22, 2007
Prognostic factors in extrapulmonary small cell carcinomas. A large retrospective studyYu-Lin Lin, Chih-Yuan Chung, Cheng-Shyong Chang, et al.
Histopathology|October 27, 2015
Traditional serrated adenoma with BRAF mutation is associated with synchronous/metachronous BRAF-mutated serrated lesionsJia-Huei Tsai, Chien-Hsuan Cheng, Chien-Chuan Chen, et al.
World Journal of Surgical Oncology|November 7, 2014
Neoadjuvant bevacizumab and chemoradiotherapy in locally advanced rectal cancer: early outcome and technical impact on toxicityChia-Chun Wang, Jin-Tung Liang, Chiao-Ling Tsai, et al.
Anticancer Research|July 31, 2012
Metastasectomy of Krukenberg tumors may be associated with survival benefits in patients with metastatic gastric cancerLi-Chun Lu, Yu-Yun Shao, Chih-Hung Hsu, et al.
BMC Cancer|September 26, 2023
Etiological analysis of infection after CRS + HIPEC in patients with PMPRui Yang, Xin Zhao, Yu-Bin Fu, et al.
Molecular Oncology|October 30, 2012
MEK inhibitors reverse resistance in epidermal growth factor receptor mutation lung cancer cells with acquired resistance to gefitinibMing-Hung Huang, Jih-Hsiang Lee, Ya-Ju Chang, et al.
Clinical and Translational Gastroenterology|December 15, 2012
CXCR4 expression predicts early liver recurrence and poor survival after resection of pancreatic adenocarcinomaWei-Chih Liao, Hsiu-Po Wang, Hsin-Yi Huang, et al.
Cancer Medicine|December 10, 2019
Establishment of patient-derived xenograft model of peritoneal mucinous carcinomatosis with signet ring cells and in vivo study on the efficacy and toxicity of intraperitoneal injection of 5-fluorouracilYu-Lin Lin, Jue Zhang, Feng-Cai Yan, et al.
Fish & Shellfish Immunology|March 17, 2024
Establishment of a cobia (Rachycentron canadum) gill cell line: A valuable tool for immune response studiesThi Hang Ho, Hoang Trieu Quan Tran, Chun-Hung Liu, et al.
BMC Cancer|May 26, 2016
Primary tumor site is a useful predictor of cetuximab efficacy in the third-line or salvage treatment of KRAS wild-type (exon 2 non-mutant) metastatic colorectal cancer: a nationwide cohort studyKuo-Hsing Chen, Yu-Yun Shao, Ho-Min Chen, et al.
Pageof 7